Treatment of lung cancer cells with SM-3 resulted in autophagic cell death, as evidenced by the conversion of LC3I to LC3II, along with increased levels of ATG7, ATG5, and p62 (Fig. 10B). The gene discussed is SQSTM1; the disease is lung carcinoma.